ClinicalTrials.gg
RecruitingNCT06706154Updated Nov 26, 2024

Exercise Capacity in Kidney Transplant Recipients

An observational study in Renal Transplantation, sponsored by Hacettepe University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-11-26.

Sponsored by Hacettepe University · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 9 months ago, but the record still lists the study as recruiting.
  • Started Aug 2024; still recruiting 2 years 2 months later.
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
27
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study aimed to determine the determinants of 6 minute walk test distance in patients with kidney transplant recipients.

02

Conditions studied

  • Renal Transplantation
03

In context

Lead sponsor

Hacettepe University is the lead sponsor of 1,001 studies on the registry; 215 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with kidney transplantation will be included.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with kidney transplantation
  • At least 6 months after the kidney transplant
  • Being aged 18-65
  • Not having regular exercise habits
  • Voluntary participation in the study

Exclusion criteria

Exclusion Criteria:

  • Having a musculoskeletal problem that may interfere with the tests
  • Having neurological impairment
  • Having chronic lung disease
  • Having had any cardiovascular event in the last 6 months
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
27 participants (estimated)
Patient registry
No

Groups and cohorts

  • Kidney transplant recipients
06

What researchers measure

Primary outcomes

  1. Exercise capacity

    Will be evaluated with 6 minute walk test. After the test, total walking distance will be recorded.

    Time frame: 1st day

  2. Respiratory function

    FEV1, FVC, FEV1/FVC, PEF, FEF25-75 will be measured by lung function test.

    Time frame: 1st day

  3. Respiratory muscle strength

    Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) will be measured using a mouth pressure device.

    Time frame: 1st day

  4. Musle function

    Knee extensor and hand grip strength will be evaluated with a dynamometer.

    Time frame: 1st day

Secondary outcomes

  1. Physical activity

    Physical activity level will be evaluated using International Physical Activity Questionnaire-Short form. This questionnaire lists activities and asks for estimates of the duration and frequency of each activity in the past week. The durations are multiplied by the MET value for each activity and the results for all items are summed to give an overall physical activity score.

    Time frame: 1st day

07

Study locations

1 of 1 sites recruiting
  • Hacettepe University
    Ankara, Turkey (Türkiye)
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06706154
Responsible party
Merve Firat (Assistant Professor, Hacettepe University) — Principal investigator
First posted
Nov 26, 2024
Start date
Aug 17, 2024
Primary completion
Jan 2025 (estimated)
Completion
May 2025 (estimated)
Last update
Nov 26, 2024

Study contacts

Merve Firat
Contact
mervefirat@ahievran.edu.tr
+90 850 441 02 44

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion